These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8950008)
21. Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing. Ito R; Hayen A J Neurosci; 2011 Apr; 31(16):6001-7. PubMed ID: 21508225 [TBL] [Abstract][Full Text] [Related]
22. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning. Ruob C; Weiner I; Feldon J Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938 [TBL] [Abstract][Full Text] [Related]
23. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. Pierce RC; Kalivas PW J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128 [TBL] [Abstract][Full Text] [Related]
24. Differential influence of the ventral subiculum on dopaminergic responses observed in core and dorsomedial shell subregions of the nucleus accumbens in latent inhibition. Peterschmitt Y; Meyer F; Louilot A Neuroscience; 2008 Jun; 154(3):898-910. PubMed ID: 18486351 [TBL] [Abstract][Full Text] [Related]
25. Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus. Murphy CA; Pezze M; Feldon J; Heidbreder C Neuroscience; 2000; 97(3):469-77. PubMed ID: 10828530 [TBL] [Abstract][Full Text] [Related]
26. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response. Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523 [TBL] [Abstract][Full Text] [Related]
27. The switching model of latent inhibition: an update of neural substrates. Weiner I; Feldon J Behav Brain Res; 1997 Oct; 88(1):11-25. PubMed ID: 9401704 [TBL] [Abstract][Full Text] [Related]
28. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229 [TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour. Murphy ER; Robinson ES; Theobald DE; Dalley JW; Robbins TW Eur J Neurosci; 2008 Jul; 28(2):353-63. PubMed ID: 18702706 [TBL] [Abstract][Full Text] [Related]
30. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. Parkinson JA; Olmstead MC; Burns LH; Robbins TW; Everitt BJ J Neurosci; 1999 Mar; 19(6):2401-11. PubMed ID: 10066290 [TBL] [Abstract][Full Text] [Related]
31. Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition. Konstandi M; Kafetzopoulos E Pharmacol Biochem Behav; 1993 Apr; 44(4):751-4. PubMed ID: 8469686 [TBL] [Abstract][Full Text] [Related]
32. The role of the nucleus accumbens shell in the mediation of the reinforcing properties of a safety signal in free-operant avoidance: dopamine-dependent inhibitory effects of d-amphetamine. Fernando AB; Urcelay GP; Mar AC; Dickinson TA; Robbins TW Neuropsychopharmacology; 2014 May; 39(6):1420-30. PubMed ID: 24336447 [TBL] [Abstract][Full Text] [Related]
33. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines. Giorgi O; Piras G; Lecca D; Corda MG Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292 [TBL] [Abstract][Full Text] [Related]
34. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. Boye SM; Grant RJ; Clarke PB Neuropharmacology; 2001 May; 40(6):792-805. PubMed ID: 11369033 [TBL] [Abstract][Full Text] [Related]
35. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Swanson CJ; Heath S; Stratford TR; Kelley AE Pharmacol Biochem Behav; 1997 Dec; 58(4):933-45. PubMed ID: 9408198 [TBL] [Abstract][Full Text] [Related]
36. Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition. Bethus I; Muscat R; Goodall G Behav Neurosci; 2006 Jun; 120(3):554-62. PubMed ID: 16768607 [TBL] [Abstract][Full Text] [Related]
37. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats. Ishiwari K; Madson LJ; Farrar AM; Mingote SM; Valenta JP; DiGianvittorio MD; Frank LE; Correa M; Hockemeyer J; Müller C; Salamone JD Behav Brain Res; 2007 Mar; 178(2):190-9. PubMed ID: 17223207 [TBL] [Abstract][Full Text] [Related]
38. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. Schiller D; Zuckerman L; Weiner I J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871 [TBL] [Abstract][Full Text] [Related]
39. Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli. Nelson AJ; Thur KE; Marsden CA; Cassaday HJ Int J Neuropsychopharmacol; 2012 May; 15(4):485-96. PubMed ID: 21557885 [TBL] [Abstract][Full Text] [Related]
40. Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens. Dalley JW; Thomas KL; Howes SR; Tsai TH; Aparicio-Legarza MI; Reynolds GP; Everitt BJ; Robbins TW Eur J Neurosci; 1999 Apr; 11(4):1265-74. PubMed ID: 10103121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]